Catalyst Wire Dossier Catalyst Wire Dossier

ARC-AAT

· Arrowhead Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ARC-AAT, covering 2018-08-03 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels [Phase 2]

See pricing